Potential utility of an expression array signature for predicting anthracycline responsiveness or resistance

J Clin Oncol. 2012 Feb 1;30(4):357-61. doi: 10.1200/JCO.2011.35.1023. Epub 2011 Dec 27.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Resistance, Neoplasm*
  • Epirubicin / therapeutic use*
  • Female
  • Humans

Substances

  • Antibiotics, Antineoplastic
  • Epirubicin